TCL Archive In Brief: Daniel Nixon Of Emory to Head Prevention Program; Henderson To Get Rosenthal Award January 30, 1987
TCL Archive In Brief: Cancer Act Renewal Hearings Completed ; Administration Stays With Objections To More Centers, Specific Budget Figures February 22, 1974
TCL Archive The shadow of Iressa lingered over the FDA Oncologic Drugs Advisory Committee as the panel voted down Genasense (Genta Inc.) and RSR13 (Allos Therapeutics Inc.) at its May 3 meeting. If anyone thought the bar had been lowered for drug approvals, they were mistaken. May 7, 2004
